A combined analysis of immunogenicity, antibody kinetics and vaccine efficacy from phase 2 trials of the RTS,S malaria vaccine.

Autor: White, Michael1 m.white08@imperial.ac.uk, Bejon, Philip2,3 pbejon@well.ox.ac.uk, Olotu, Ally2 aolotu@kemri-wellcome.org, Griffin, Jamie1 jamie.griffin@imperial.ac.uk, Bojang, Kalifa4 kbojang@mrc.gm, Lusingu, John5 jpalusingu@gmail.com, Salim, Nahya6 nsalim@ihi.or.tz, Abdulla, Salim6 sabdulla@ihi.or.tz, Otsyula, Nekoye7 nekoye.otsyula@usamru-k.org, Agnandji, Selidji8,9 agnandjis@lambarene.org, Lell, Bertrand8,9 bertrand.lell@gmail.com, Asante, Kwaku10 akupoku.asante@kintampo-hrc.org, Owusu-Agyei, Seth10 seth.owusu-agyei@kintampo-hrc.org, Mahama, Emmanuel10 Emmanuel.mahama@kintampo-hrc.org, Agbenyega, Tsiri11 tsiri@ghana.com, Ansong, Daniel11 ansongd@yahoo.com, Sacarlal, Jahit12,13 jahit.sacarlal@manhica.net, Aponte, John12,14 john.aponte@cresib.cat, Ghani, Azra1 a.ghani@imperial.ac.uk
Zdroj: BMC Medicine. 2014, Vol. 12 Issue 1, p1-21. 21p. 1 Color Photograph, 3 Charts, 1 Graph.
Databáze: Academic Search Ultimate